These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Magnetic resonance spectroscopy as marker for neurodegeneration in X-linked adrenoleukodystrophy. van de Stadt SIW; Schrantee A; Huffnagel IC; van Ballegoij WJC; Caan MWA; Pouwels PJW; Engelen M Neuroimage Clin; 2021; 32():102793. PubMed ID: 34461432 [TBL] [Abstract][Full Text] [Related]
8. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Eichler FS; Itoh R; Barker PB; Mori S; Garrett ES; van Zijl PC; Moser HW; Raymond GV; Melhem ER Radiology; 2002 Oct; 225(1):245-52. PubMed ID: 12355012 [TBL] [Abstract][Full Text] [Related]
9. Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy. Turk BR; Theisen BE; Nemeth CL; Marx JS; Shi X; Rosen M; Jones RO; Moser AB; Watkins PA; Raymond GV; Tiffany C; Fatemi A JAMA Neurol; 2017 May; 74(5):519-524. PubMed ID: 28288261 [TBL] [Abstract][Full Text] [Related]
10. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. van Geel BM; Bezman L; Loes DJ; Moser HW; Raymond GV Ann Neurol; 2001 Feb; 49(2):186-94. PubMed ID: 11220738 [TBL] [Abstract][Full Text] [Related]
12. Prominent brain axonal damage and functional reorganization in "pure" adrenomyeloneuropathy. Marino S; De Luca M; Dotti MT; Stromillo ML; Formichi P; Galluzzi P; Mondelli M; Bramanti P; Federico A; De Stefano N Neurology; 2007 Sep; 69(12):1261-9. PubMed ID: 17875914 [TBL] [Abstract][Full Text] [Related]
13. [X-linked adrenoleukodystrophy]. Aubourg P Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287 [TBL] [Abstract][Full Text] [Related]
14. Reproductive function in men affected by X-linked adrenoleukodystrophy/adrenomyeloneuropathy. Stradomska TJ; Kubalska J; Janas R; Tylki-Szymanska A Eur J Endocrinol; 2012 Feb; 166(2):291-4. PubMed ID: 22048970 [TBL] [Abstract][Full Text] [Related]
15. Quantitative proton magnetic resonance spectroscopy of children with adrenoleukodystrophy before and after hematopoietic stem cell transplantation. Wilken B; Dechent P; Brockmann K; Finsterbusch J; Baumann M; Ebell W; Korenke GC; Pouwels PJ; Hanefeld FA; Frahm J Neuropediatrics; 2003 Jun; 34(5):237-46. PubMed ID: 14598229 [TBL] [Abstract][Full Text] [Related]
16. Childhood adrenoleukodystrophy: assessment with proton MR spectroscopy. Tzika AA; Ball WS; Vigneron DB; Dunn RS; Nelson SJ; Kirks DR Radiology; 1993 Nov; 189(2):467-80. PubMed ID: 8210375 [TBL] [Abstract][Full Text] [Related]
17. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Kruse B; Barker PB; van Zijl PC; Duyn JH; Moonen CT; Moser HW Ann Neurol; 1994 Oct; 36(4):595-608. PubMed ID: 7944292 [TBL] [Abstract][Full Text] [Related]
18. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Oz G; Tkác I; Charnas LR; Choi IY; Bjoraker KJ; Shapiro EG; Gruetter R Neurology; 2005 Feb; 64(3):434-41. PubMed ID: 15699371 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013 [TBL] [Abstract][Full Text] [Related]
20. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil". van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]